ConductScience.org, home

Paper · 11480433

Fetal toxic effects and angiotensin-II-receptor antagonists.

Martinovic J and 4 others. Lancet, 2001. Cited by 83 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fetal toxic effects and angiotensin-II-receptor antagonists. Papers, record 11480433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11480433

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fetal toxic effects and angiotensin-II-receptor antagonists.
PubMed
Journal
Lancet
PubMed
Year
2001
PubMed
Publication types
Case Reports, Comment, Journal Article
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2015-11-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martinovic JJ
2Benachi AA
3Laurent NN
4Daikha-Dahmane FF
5Gubler MCM C

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Abnormalities, Drug-InducedMajor topic
Angiotensin Receptor AntagonistsMajor topic
Antihypertensive AgentsMajor topic
HypertensionMajor topic
LosartanMajor topic
Pregnancy Complications, CardiovascularMajor topic
TetrazolesMajor topic
ValineMajor topic
Adult
Angiotensin II
Female
Humans
Pregnancy
Valsartan

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on11,211,003Losartan and fetal toxic effects.https://conductscience.org/library/papers/11211003

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
42,332,008Losartan shows limited benefit in preclinical models of Geleophysic dysplasia.Sci Rep2026https://conductscience.org/library/papers/42332008PubMed
41,304,543Maternal Exposure to 2,4-Di-tert-butylphenol During Pregnancy in a Mouse Model Leads to Abnormal Development of the Urinary System in Offspring.Toxics2025https://conductscience.org/library/papers/41304543PubMed
40,164,775Ureter development and associated congenital anomalies.Nat Rev Nephrol2025https://conductscience.org/library/papers/40164775PubMed
40,111,092Nephron progenitor fate is modulated by angiotensin type 1 receptor signaling in human kidney organoids.Stem Cells2025https://conductscience.org/library/papers/40111092PubMed
39,397,601Vitamin A Deficiency Disturbs Ret Expression and Induces Urinary Tract Developmental Abnormalities in Mice.Am J Nephrol2025https://conductscience.org/library/papers/39397601PubMed
37,524,861The genetics and pathogenesis of CAKUT.Nat Rev Nephrol2023https://conductscience.org/library/papers/37524861PubMed
36,875,461Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/36875461PubMed
35,861,872Clinical and pathological investigation of oligomeganephronia.Pediatr Nephrol2023https://conductscience.org/library/papers/35861872PubMed
33,768,328Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor.Pediatr Nephrol2021https://conductscience.org/library/papers/33768328PubMed
31,718,018Prenatal Diagnosis of Autosomal Recessive Renal Tubular Dysgenesis with Anhydramnios Caused by a Mutation in the AGT Gene.Diagnostics (Basel)2019https://conductscience.org/library/papers/31718018PubMed

1 to 10 of 37

See all 37 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11480433

GET https://conductscience.org/api/papers/v1/11480433/cited_by?page=2